Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Emission Factor Recommendation for Life Cycle Assessments with Generative AI.
Journal: Environmental science & technology
Published: March 21, 2025
Automated loss of pulse detection on a consumer smartwatch.
Journal: Nature
Published: November 19, 2024
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study.
Journal: Breast cancer research : BCR
Published: June 26, 2024
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis.
Journal: JCO precision oncology
Published: April 26, 2023
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Journal: The Lancet. Oncology
Published: February 23, 2023
A Low-power wearable acoustic device for accurate invasive arterial pressure monitoring.
Journal: Communications medicine
Published: October 06, 2022
VCSEL: PRIORITIZING SNP-SET BY PENALIZED VARIANCE COMPONENT SELECTION.
Journal: The annals of applied statistics
Published: February 24, 2022
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 15, 2021
Closed-loop wearable naloxone injector system.
Journal: Scientific reports
Published: October 31, 2021
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 15, 2021
GWAS of longitudinal trajectories at biobank scale.
Journal: American journal of human genetics
Published: August 10, 2021
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 26, 2021
Last Updated: 09/26/2026